France · 
Who invested in BiPER Therapeutics?
BiPER Therapeutics's investors include Bpifrance and iSeed.
France · Seed startup
Who invested in BiPER Therapeutics
Funding summaryUpdated 26 Oct 2026
$1.2Mraised across 1 round since 2025, from 1 source
- Latest round
- Seed, $1.2MDec 2025
- Investors
- 2
The rounds
- Dec 2025
Founders and team
From BiPER Therapeutics's own website: 5 on the team.
- Mehdi ChelbiChief Executive Officer
- Mickel CerezoChief Scientific Officer
- Noomane FehriChief Financial Officer
- Stephane MilotChief Financial Officer
- Thierry PasseronProfessor and Chair of Dermatology at Nice Hospital
AdvisersCyril Ronco
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about BiPER Therapeutics
How much has BiPER Therapeutics raised?
BiPER Therapeutics has raised $1.2M across 1 round since 2025.
When did BiPER Therapeutics last raise?
BiPER Therapeutics's most recent round was a Seed of $1.2M in Dec 2025.
What was BiPER Therapeutics's biggest round?
Its most recent round, $1.2M in Dec 2025, is also its largest on record.
Who backed BiPER Therapeutics first?
BiPER Therapeutics's first round on record, in Dec 2025, was backed by Bpifrance and iSeed.
What stage is BiPER Therapeutics at?
BiPER Therapeutics's latest named round is a Seed, in Dec 2025.
Where is BiPER Therapeutics based?
BiPER Therapeutics is based in France.
Companies like BiPER Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.